MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Tourette syndrome treated by continuous electrical neuromodulation (DBS): Targeting the comorbidities?

    F. Cyprien, L. Cif, V. Gonzalez, E. Sanrey, J. Perez, P. Coubes (Montpellier, France)

    Objective: To assess the response to deep brain stimulation (DBS) in refractory Tourette syndrome (rTS) of both tics and behavioural comorbidities. Background: Gilles de la…
  • 2016 International Congress

    VOP/ZI deep brain stimulation for the relief of tremor in multiple sclerosis

    V. Levi, G. Messina, R. Cordella, I. Dones, A. Franzini (Milano, Italy)

    Objective: To evaluate the therapeutic effect of electrical chronic stimulation of ventralis oralis posterior and zona incerta (VOP/ZI) in 3 subjects affected by severely disabling…
  • 2016 International Congress

    The Catalan multiple system atrophy-registry (CMSAR)

    F. Antonelli, E. Muñoz, J. Pagonabarraga, J. Hernández-Vara, A. Bayes, O. de Fabregues, F. Valldeoriola, E. Tolosa, Y. Compta, M. Ezquerra, R. Fernandez, M. Calopa, S. Jauma, M. Pujol, V. Puente, A. Cámara, L. Planellas, M.J. Martí (Barcelona, Spain)

    Objective: To collect comprehensive and standardized clinical data and to create a repository of biological samples and cell lines from probable and possible MSA patients…
  • 2016 International Congress

    A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

    T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)

    Objective: To identify PSP/CBD progression biomarkers both to improve understanding of disease etiology and course, and to provide crucial tools to enhance the likelihood of…
  • 2016 International Congress

    Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

    O.L. Tondiy (Kharkiv, Ukraine)

    Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
  • 2016 International Congress

    Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands

    L.L. Farrell, E. Nosova, S. Bech, I. Guella, M.J. Farrer, M.S. Petersen (Vancouver, BC, Canada)

    Objective: To investigate genetic variability in CYP2B6, PCB levels and Parkinson's disease in the Faroese. Background: Polychlorinated biphenyls (PCBs) are persistent man-made highly toxic pollutants…
  • 2016 International Congress

    Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy

    T. Uyar, K. Paksoy, C. Çokluk (Rize, Turkey)

    Objective: To describe a patient with bilateral cerebral and cerebellar calcification secondary to a hypoparathyroidsm. Background: Fahr's Syndrome (FS) is a rare disorder and may…
  • 2016 International Congress

    Association between clinical features and pre- and post-synaptic dopaminergic dysfunction in multiple system atrophy: [18F]-FP-CIT PET and [18F]-FDG PET analyses

    H.S. Ryu, M. Oh, M.J. Kim, S. You, Y.J. Kim, J. Kim, K. Kim, H. Moon, J. Oh, J.S. Kim, S.J. Chung (Seoul, Korea)

    Objective: To investigate the correlation between clinical features and pre- and post-synaptic dopaminergic dysfunction in patients with multiple system atrophy (MSA). Background: Multiple system atrophy…
  • 2016 International Congress

    The importance of Ishihara testing in early diagnosing of Parkinson’s disease

    S. Mirdedaev, K. Mirzayeva, D. Baykhonova (Tashkent, Uzbekistan)

    Objective: Studying the importance of color differentiating in order to detect PD at earlier stages. Methods: Ishihara Test (IT) was experimented in 30 patients at…
  • 2016 International Congress

    Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism

    Y. Kim, J.M. Seok, H.J. Kim, J. Youn, B.J. Kim, J.W. Cho (Seoul, Korea)

    Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley